Nextech Invest’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Nextech Invest's AVTX Position: Q3 2026 in Review
Nextech Invest opened a new position in Avalo Therapeutics (AVTX) in Q3 2026: 766,000 shares worth $11.7M. The stake represents 0.53% of the portfolio and ranks #13 among its holdings.
148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Nextech Invest held 766,000 shares of Avalo Therapeutics worth $11.7M as of Q3 2026.
- Avalo Therapeutics was a new Nextech Invest position in Q3 2026.
- Avalo Therapeutics made up 0.53% of Nextech Invest's portfolio in Q3 2026, its #13 holding.
- 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Nextech Invest's 13F filing for Q3 2026, filed 16 Nov 2026.